Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Surgical Equipment

Medtronic Inc.: Abre Venous Stent Systems Recalled for Potential Sterile Package Breach

Agency Publication Date: March 19, 2024
Share:
Sign in to monitor this recall

Summary

Medtronic Inc. is recalling 65 units of the Abre Venous Self-expanding Stent System because there is a risk that the sterile packaging may have been breached. This recall affects three specific product models distributed worldwide, including 65 units in the United States and several other countries. Consumers and healthcare providers should identify if their specific batch numbers are affected and contact the manufacturer for further instructions regarding these medical devices.

Risk

If the sterile packaging is breached, the stent system may become contaminated with bacteria or other pathogens, potentially leading to serious infections or other complications when the device is used during a medical procedure.

What You Should Do

  1. Check your Abre Venous Self-expanding Stent System for the following product and batch numbers: AB9U14080090 (Batch B456626), AB9U18100090 (Batch B456811), or AB9G14100090 (Batch B460542).
  2. Verify the UDI/DI codes on the packaging: 00643169796294, 00643169796409, or 00763000547325.
  3. If your device matches any of these batch numbers, do not use the product and set it aside to prevent accidental use.
  4. Contact your healthcare provider or Medtronic Inc. immediately for further instructions and information on returning the affected units.
  5. For additional questions or to report issues, contact the FDA at 1-888-463-6332 (1-888-INFO-FDA) or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Contact manufacturer for instructions

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: Abre Venous Self-expanding Stent System (AB9U14080090)
Model / REF:
AB9U14080090
UPC Codes:
00643169796294
Lot Numbers:
Batch Number B456626
Product: Abre Venous Self-expanding Stent System (AB9U18100090)
Model / REF:
AB9U18100090
UPC Codes:
00643169796409
Lot Numbers:
Batch Number B456811
Product: Abre Venous Self-expanding Stent System (AB9G14100090)
Model / REF:
AB9G14100090
UPC Codes:
00763000547325
Lot Numbers:
Batch Number B460542

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94167
Status: Active
Manufacturer: Medtronic Inc.
Manufactured In: United States
Units Affected: 65 units
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.